Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting

NCT07236814 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT07236814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07236814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting
Lead sponsor
Capital Medical University
Phase
Phase 3
Overall status
Recruiting
Start date
November 28, 2025
Completion date
March 6, 2027
Enrollment
384 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza